Japan approves GSK’s Sotrovimab COVID-19 antibody treatment

Japan has approved GlaxoSmithKline and Vir Biotechnology’s Sotrovimab as an antibody treatment for coronavirus, Health Minister Norihisa Tamura said on Monday.
( read original story …)